Safety and Effectiveness of D-Serine in Schizophrenia - Contacts and Locations - ClinicalTrials.gov

ClinicalTrials.gov

Home

Search


	Full Text View


	Tabular View


	Contacts and Locations


	Related Studies

Safety and Effectiveness of D-Serine in Schizophrenia

This study is currently recruiting participants.
Information provided by National Institute of Mental Health (NIMH)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00322023

Contacts


Contact: Daniel C. Javitt, MD, PhD	845-398-6534	javitt@nki.rfmh.org

Contact: Gail Silipo, MA	845-398-6536	silipo@nki.rfmh.org

Locations


United States, Connecticut
	Yale University School of Medicine			Recruiting
	New Haven, Connecticut, United States, 06512
	Contact: Scott W. Woods, MD 203-974-7038 scott.woods@yale.edu
	Principal Investigator: Scott W. Woods, MD

United States, New York
	The Zucker Hillside Hospital			Recruiting
	Glen Oaks, New York, United States, 11004
	Contact: Anil Malhotra, MD 718-470-8418 malhotra@lij.edu
	Contact: Susan Ray, MA 718-470-8442 SRay@lij.edu
	Principal Investigator: Anil Malhotra, MD
	Principal Investigator: Barbara Cornblatt, PhD
	The Nathan S. Kline Institute for Psychiatric Research			Recruiting
	Orangeburg, New York, United States, 10962
	Contact: Daniel C. Javitt, MD, PhD 845-398-6534 javitt@nki.rfmh.org
	Contact: Gail Silipo, MA 845-398-6536 silipo@nki.rfmh.org
	Principal Investigator: Daniel C. Javitt, MD, PhD

Sponsors and Collaborators

National Institute of Mental Health (NIMH)

Investigators


Principal Investigator:	Daniel C. Javitt, MD, PhD	Nathan Kline Institute